AR011460A1 - TETRAHYDROPYRIDINE COMPOUNDS, CONTAINING MEDICINES AND USE OF SUCH COMPOUNDS FOR THE PREPARATION OF MEDICINES - Google Patents
TETRAHYDROPYRIDINE COMPOUNDS, CONTAINING MEDICINES AND USE OF SUCH COMPOUNDS FOR THE PREPARATION OF MEDICINESInfo
- Publication number
- AR011460A1 AR011460A1 ARP980101329A AR011460A1 AR 011460 A1 AR011460 A1 AR 011460A1 AR P980101329 A ARP980101329 A AR P980101329A AR 011460 A1 AR011460 A1 AR 011460A1
- Authority
- AR
- Argentina
- Prior art keywords
- hydrogen
- compounds
- alkoxy
- signifies
- substituents
- Prior art date
Links
Abstract
Compuestos de la formula I en la cual R1 significa alquilo C1-4, R2 significa alquilo C1-4 o hidroxi-alquilo C1-4, R3 significa hidrogeno ohalogeno, uno de los sustituyentes R4a y R4b significa hidrogeno, y el otro significa hidrogeno,hi droxi, alcoxi C1-4, alcoxi C1-4-alcoxi C1-4 o alquilC1-4-carboniloxi, o en la cual R4a y R4b juntos representan O (oxígeno), uno de los sustituyentes R5a y R5b significa hidrogeno, y el otro significa hidrogeno,hidroxi, alcoxi C1-4, alcoxi C1-4-alcox i C1-4 o alquil C1-4-carboniloxi, o en la cual R5a y R5b juntos representan O(oxígeno), o en la cual uno de lossustituyentes R4a y R4b por una parte y uno de los sustituyentes R5a y R5b por otra parte significa en cada caso hidrogeno, y losotros sustituyentes en cadacaso forman juntos un radical metilenodioxi (-O-CH2-O-) o un radical etilenodioxi (-O-CH2-CH2-O-), donde R4a, R4b, R5a y R5b no tienensimultáneamente el significado de hidrogeno, R6 significa hidrogeno,halogeno, alqu ilo C1-4, alcoxi C1-4, alcoxi C1-4-carbonilamino, alcoxi C1-4-alcoxi C1-4--carbonilamino o trifluorometilo y R7 significa hidrogeno, halogeno, alquilo C1-4 o alcoxi C1-4, y sus sales. Los compuestos de formula I y sus sales,sonutiles para la prep aracion de medicamentos destinados a la prevencion y el tratamiento de enfermedades gastrointestinales.Compounds of formula I in which R1 signifies C1-4 alkyl, R2 signifies C1-4 alkyl or hydroxy-C1-4 alkyl, R3 signifies hydrogen or halogen, one of the substituents R4a and R4b signifies hydrogen, and the other signifies hydrogen, hydroxy, C1-4alkoxy, C1-4alkoxy-C1-4alkoxy or C1-4alkylcarbonyloxy, or in which R4a and R4b together represent O (oxygen), one of the substituents R5a and R5b stands for hydrogen, and the other means hydrogen, hydroxy, C1-4 alkoxy, C1-4 alkoxy-C1-4 alkoxy or C1-4alkylcarbonyloxy, or in which R5a and R5b together represent O (oxygen), or in which one of the substituents R4a and R4b on the one hand and one of the substituents R5a and R5b on the other hand signifies hydrogen in each case and the other substituents in each case together form a methylenedioxy radical (-O-CH2-O-) or an ethylenedioxy radical (-O- CH2-CH2-O-), where R4a, R4b, R5a and R5b do not simultaneously have the meaning of hydrogen, R6 means hydrogen, halogen, C1-4alkyl, C1-4alkoxy, a C1-4-alkoxy-carbonylamino, C1-4-alkoxy-C1-4-alkoxycarbonylamino or trifluoromethyl and R7 signifies hydrogen, halogen, C1-4-alkyl or C1-4-alkoxy, and their salts. The compounds of formula I and their salts are useful for the preparation of drugs intended for the prevention and treatment of gastrointestinal diseases.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19712322 | 1997-03-24 | ||
| DE19747929 | 1997-10-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR011460A1 true AR011460A1 (en) | 2000-08-16 |
Family
ID=26035179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980101329 AR011460A1 (en) | 1997-03-24 | 1998-03-24 | TETRAHYDROPYRIDINE COMPOUNDS, CONTAINING MEDICINES AND USE OF SUCH COMPOUNDS FOR THE PREPARATION OF MEDICINES |
Country Status (8)
| Country | Link |
|---|---|
| AR (1) | AR011460A1 (en) |
| CO (1) | CO4940425A1 (en) |
| GE (1) | GEP20012445B (en) |
| HR (1) | HRP980147B1 (en) |
| MY (1) | MY116727A (en) |
| PE (1) | PE61999A1 (en) |
| SA (1) | SA98190059B1 (en) |
| TW (1) | TW593320B (en) |
-
1998
- 1998-03-16 MY MYPI9801137 patent/MY116727A/en unknown
- 1998-03-19 GE GEAP19984985A patent/GEP20012445B/en unknown
- 1998-03-19 TW TW87104064A patent/TW593320B/en not_active IP Right Cessation
- 1998-03-20 PE PE00020198A patent/PE61999A1/en not_active Application Discontinuation
- 1998-03-20 HR HRP980147 patent/HRP980147B1/en not_active IP Right Cessation
- 1998-03-24 AR ARP980101329 patent/AR011460A1/en active IP Right Grant
- 1998-03-24 CO CO98016265A patent/CO4940425A1/en unknown
- 1998-05-12 SA SA98190059A patent/SA98190059B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GEP20012445B (en) | 2001-05-25 |
| MY116727A (en) | 2004-03-31 |
| CO4940425A1 (en) | 2000-07-24 |
| PE61999A1 (en) | 1999-06-19 |
| SA98190059B1 (en) | 2006-08-12 |
| HRP980147B1 (en) | 2002-08-31 |
| HRP980147A2 (en) | 1999-02-28 |
| TW593320B (en) | 2004-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR034897A1 (en) | N-MONOACILATED DERIVATIVES OF O-PHENYLENDIAMINS, THEIR HETEROCICLICAL ANALOGS OF SIX MEMBERS AND THEIR USE AS PHARMACEUTICAL AGENTS | |
| CO5011096A1 (en) | MEDICINES CONTAINING ANTAGONISTS OF THE 5-HT3 RECEPTOR FOR THE TREATMENT OF IBS | |
| AR020590A1 (en) | 7-DIAZAPURINA-N-6 REPLACED, A METHOD FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND IT | |
| MX9203755A (en) | IONTOPHORETICAL SUPPLY DEVICE FOR DRUGS OR THERAPEUTIC AGENTS, EQUIPPED WITH AN ADHESIVE OF ELECTRO-TRANSPORTATION. | |
| ES2091877T3 (en) | USE OF ANGIOTENSIN II ANTAGONISTS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF HYPERURICEMIA. | |
| TR200402579T4 (en) | Crystalline monohydrate, its method of manufacture and its use in the manufacture of a drug substance | |
| ES2175161T3 (en) | PIPERAZINE DERIVATIVES AS TAQUIQUININE ANTAGONISTS. | |
| LU88576I2 (en) | RISPERIDONE and its pharmaceutically acceptable salts (Risperdal R) | |
| DE3687541D1 (en) | USE OF CALCIUM ANTAGONISTS FOR THE PRODUCTION OF COMPOSITIONS FOR WITHDRAWAL SYMPTOMS. | |
| MY108616A (en) | Pyridine and pyridine n-oxide derivatives of diaryl methyl piperidines of piperazines, and compositions and methods of use thereof | |
| DK0879820T3 (en) | Benzamide analogues useful as PARP (ADP-Ribosyltransferase, ADPRT) DNA repair enzyme inhibitors | |
| ES557835A0 (en) | A PROCEDURE FOR PREPARING A PHARMACEUTICAL FORMULATION CONTAINING 3'-AZIDO-3'-DEOXYTHIMIDINE OR ONE OF ITS PHARMACEUTICALLY ACCEPTABLE DERIVATIVES. | |
| CY1107592T1 (en) | BULGARIAN ORAL RISK INSTRUMENT | |
| UY26370A1 (en) | "IMIDAZO-5-IL-AMICAS BICÍCLICAS, DRUGS CONTAINING THEM, THEIR USE FOR THE PREPARATION OF DRUGS AND PROCEDURE FOR THE PREPARATION". | |
| UY27850A1 (en) | NEW QUINUCLIDINE CARBAMATES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| DK160981C (en) | ARYLSULPHONYLURINE DERIVATIVES, PROCEDURES FOR THE PRODUCTION THEREOF, APPLICATION OF THESE AS THERAPEUTIC AND ANTINEOPLASTIC AGENTS AND PHARMACEUTICAL AGENTS CONTAINING SUCH DERIVATIVES | |
| ATE312621T1 (en) | PHARMACEUTICAL FORMULATIONS OF THYROID HORMONES | |
| ES2061688T3 (en) | PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A CALCITONINE AND A GLICIRRICINATE AS IMPROVER OF ABSORPTION. | |
| ES2179533T3 (en) | MEDICINAL FORMULATION WITH CONTROLLED RELEASE OF THE ACTIVE PRINCIPLE. | |
| AR022413A1 (en) | USE OF PIRIDAZINO DERIVATIVES (4,5-B) INDOL-1-ACETAMIDE, FOR THE PREPARATION OF DRUGS INTENDED FOR DISEASES OF THE NERVOOSOCENTRAL SYSTEM | |
| AR013462A1 (en) | NEW PEPTIDOMIMETICOS FOR THE TREATMENT OF BONE DISORDERS, METHODS FOR ITS PRODUCTION AND DRUGS THAT CONTAIN THESE COMPOUNDS | |
| ES2191942T3 (en) | NEW USE OF A SPECIFIC ANTAGONIST OF 5HT2A RECEPTORS. | |
| AR007088A1 (en) | 2,4-DIAMINOPYRIMIDINES SUBSTITUTED, INTERMEDIATE COMPOUNDS USED IN ITS PREPARATION, PROCEDURE FOR THE PREPARATION OF SUCH 2,4-DIAMINOPYRIMIDINES CONTAINED, MEDICINES THAT CONTAIN THEM AND EMPLOYMENTS OF SUCH PIRIMIDINES | |
| DK144685D0 (en) | SUBSTITUTED BENZOPYRANES, PROCEDURES FOR PREPARING THEREOF AND THEIR USE IN PHARMACEUTICALS | |
| AR018032A1 (en) | DERIVATIVES OF INDOL-ARIL SUBSTITUTED, A PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND THE USE OF SUCH COMPOUNDS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant; registration |